Phentermine-Topiramate

DRUG5 trials

Sponsors

Mayo Clinic, University of Minnesota, University of California, San Diego, The Cleveland Clinic

Conditions

Bipolar I DisorderBipolar II DisorderColitis, UlcerativeGLP - 1ObesitySchizo Affective DisorderWeight Loss

Phase 2

Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity

CompletedNCT04298203

University of MinnesotaObesity

Start: 2021-08-04End: 2026-05-22Updated: 2026-05-26

Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients

RecruitingNCT04721873

University of California, San DiegoColitis, Ulcerative, Obesity

Start: 2020-12-18End: 2024-06-30Target: 40Updated: 2023-05-16

Phase 3

Individualized Obesity Pharmacotherapy

CompletedNCT03374956

Mayo ClinicObesity

Start: 2017-12-11End: 2022-05-26Updated: 2023-07-18

Phase 4

Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)

Active, not recruitingNCT06854614

The Cleveland ClinicObesity

Start: 2025-03-01End: 2028-04-28Updated: 2025-12-12

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

RecruitingNCT07213466

Mayo ClinicBipolar I Disorder, Bipolar II Disorder, GLP - 1 +3

Start: 2026-01-19End: 2029-02-01Target: 100Updated: 2026-03-11